Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.

作者: Ursula Vinatzer , Christine Mannhalter , Margit Mitterbauer , Helga Gruener , Hildegard Greinix

DOI: 10.1002/GCC.10144

关键词:

摘要: The EVI1 gene in chromosome band 3q26 exhibits a number of properties consistent with role as an oncogene, and its expression is activated most myeloid leukemia patients with, well minority without, rearrangements. A splice variant this gene, MDS1/EVI1, acts antagonist at least some tissue culture assays. We established real-time quantitative reverse transcriptase polymerase chain reaction (RTQ-RT-PCR) assays for these mRNA variants to compare their levels quantitatively reliable manner. was overexpressed highly variable extents all 14% In samples, MDS1/EVI1 also transcribed elevated compared those healthy controls. However, although the induction comparable to, or higher than, that three five samples normal locus, true only two 13 aberration. further provide preliminary evidence RTQ-RT-PCR assay may be useful disease monitoring overexpressing EVI1.

参考文章(42)
H. Quentmeier, H. G. Drexler, Z.-B. Hu, W. Ma, M. Zaborski, R. A. F. Macleod, Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia. ,vol. 10, pp. 1025- 1040 ,(1996)
Morishita K, Yokota J, Ihle Jn, Suzukawa K, Taki T, EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC. Oncogene. ,vol. 10, pp. 1961- 1967 ,(1995)
T. Tanaka, J. Nishida, K. Mitani, S. Ogawa, Y. Yazaki, H. Hirai, Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. Journal of Biological Chemistry. ,vol. 269, pp. 24020- 24026 ,(1994) , 10.1016/S0021-9258(19)51041-9
Mineo Kurokawa, Kinuko Mitani, Kenji Irie, Tomohiro Matsuyama, Tokiharu Takahashi, Shigeru Chiba, Yoshio Yazaki, Kunihiro Matsumoto, Hisamaru Hirai, The oncoprotein Evi-1 represses TGF-Beta signalling by inhibiting Smad3 Nature. ,vol. 394, pp. 92- 96 ,(1998) , 10.1038/27945
Ulrich Lass, Cornelia Eckert, Gabriele Körner, Karlheinz Seeger, Günter Henze, Karl-Anton Kreuzer, Christian-A Schmidt, Dirk Buchwald, Tillmann Taube, Molecular Quantification of Response to Therapy and Remission Status in TEL-AML1-Positive Childhood ALL by Real-Time Reverse Transcription Polymerase Chain Reaction Cancer Research. ,vol. 61, pp. 2517- 2522 ,(2001)
JJM van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, G Saglio, E Gottardi, A Rambaldi, G Dotti, F Griesinger, A Parreira, P Gameiro, M González Diáz, M Malec, AW Langerak, JF San Miguel, A Biondi, Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. ,vol. 13, pp. 1901- 1928 ,(1999) , 10.1038/SJ.LEU.2401592
A S Perkins, R Fishel, N A Jenkins, N G Copeland, Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein Molecular and Cellular Biology. ,vol. 11, pp. 2665- 2674 ,(1991) , 10.1128/MCB.11.5.2665
J Soderholm, H Kobayashi, C Mathieu, JD Rowley, G Nucifora, The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia. ,vol. 11, pp. 352- 358 ,(1997) , 10.1038/SJ.LEU.2400584